Notice Number: NOT-DA-19-042
Key Dates
Release Date: May 29, 2019
PAR-18-437
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The purpose of the Notice is to change the Key Dates in PAR-18-437 "Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)".
Currently Reads:
Part 1. Overview Information
Key Dates
Application Due Date(s): August 20, 2018; December 20, 2018; August 20, 2019; December 20, 2019; August 20, 2020; and December 18, 2020
AIDS Application Due Date(s): August 20, 2018; December 20, 2018; August 20, 2019; December 20, 2019; August 20, 2020; and December 18, 2020
Scientific Merit Review: November 2018; March 2019; November 2019; March 2020; November 2020; and March 2021
Advisory Council Review: January 2019; May 2019; January 2020; May 2020; January 2021; and May 2021
Earliest Start Date: April 1, 2019; July 1, 2019; April 1, 2020; July 1, 2020; April 1, 2021; and July 1, 2021
Expiration Date: December 19, 2020
Modified to Read:
Part 1. Overview Information
Key Dates
Application Due Date(s): August 20, 2018; December 20, 2018; August 20, 2019; February 10, 2020, August 20, 2020; and February 10, 2021
AIDS Application Due Date(s): August 20, 2018; December 20, 2018; August 20, 2019; February 10, 2020, August 20, 2020; and February 10, 2021
Scientific Merit Review: November 2018; March 2019; November 2019; May 2020 ; November 2020; and May 2021
Advisory Council Review: January 2019; May 2019; January 2020; October 2020; January 2021; and October 2021
Earliest Start Date: April 1, 2019; July 1, 2019; April 1, 2020; August 1, 2020 ; April 1, 2021; and August 1, 2021
Expiration Date: February 11, 2021
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Amy C. Lossie, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6092
Email:lossieac@mail.nih.gov
and Human Services (HHS)
